Back to state act
Description
On 19 December 2025, the United States announced an agreement with Amgen providing the company with three years of relief from industry-specific pharmaceutical tariffs, potentially covering prospectiv...
Sign in to see full description
Intervention Details
Intervention Type
Import tariff
MAST Chapter
I: Trade-related investment measures
Implementation date
31 Jul 2026
Revocation date
20 Jan 2029
Implementation level
National
Affected flow
Inward
Announced as temporary
No
Eligible firms
firm-specific
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 60 products
Threads
See all
This intervention is not part of any Thread yet.